These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12721114)

  • 21. Sphingosine 1-phosphate enhances spontaneous transmitter release at the frog neuromuscular junction.
    Brailoiu E; Cooper RL; Dun NJ
    Br J Pharmacol; 2002 Aug; 136(8):1093-7. PubMed ID: 12163341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart.
    Russell FD; Molenaar P
    Cardiovasc Res; 2004 Sep; 63(4):673-81. PubMed ID: 15306223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protons resolve dual effects of calcium on miniature end-plate potential frequency at frog neuromuscular junctions.
    Talbot PA
    J Gen Physiol; 1989 Apr; 93(4):745-60. PubMed ID: 2543733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of the anticonvulsants phenobarbital, ethosuximide and carbamazepine on neuromuscular transmission.
    Alderdice MT; Trommer BA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):92-6. PubMed ID: 6256522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction between human urotensin II and vasodilator agents in human internal mammary artery with possible clinical implications.
    Bai XY; Liu XC; Yang Q; Tang XD; He GW
    Ann Thorac Surg; 2011 Aug; 92(2):610-6. PubMed ID: 21704284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endotoxin alters spontaneous transmitter release at the frog neuromuscular junction.
    Person RJ
    J Neurosci Res; 1977; 3(1):63-72. PubMed ID: 23437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Mg2+ on the stimulation-induced changes in transmitter release at the frog neuromuscular junction.
    Tanabe N; Morota A; Kijima H
    Zoolog Sci; 1995 Jun; 12(3):265-70. PubMed ID: 7580810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of trimethadione and its primary metabolite dimethadione on neuromuscular function and the effects of altered pH on the actions of dimethadione.
    Alderdice MT; McMillan JE
    J Pharmacol Exp Ther; 1982 Jun; 221(3):547-51. PubMed ID: 6283057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spasmogenic actions of frog urotensin II on the bladder and ileum of the frog, Rana catesbeiana.
    Yano K; Vaudry H; Conlon JM
    Gen Comp Endocrinol; 1994 Dec; 96(3):412-9. PubMed ID: 7883148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urotensin II receptor and acetylcholine release from mouse cervical spinal cord nerve terminals.
    Bruzzone F; Cervetto C; Mazzotta MC; Bianchini P; Ronzitti E; Leprince J; Diaspro A; Maura G; Vallarino M; Vaudry H; Marcoli M
    Neuroscience; 2010 Sep; 170(1):67-77. PubMed ID: 20620192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of transmitter release by muscle length in frog motor nerve terminals. Dynamics of the effect and the role of integrin-ECM interactions.
    Chen BM; Grinnell AD
    Adv Second Messenger Phosphoprotein Res; 1994; 29():383-98. PubMed ID: 7848723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Niflumic acid-induced increase in potassium currents in frog motor nerve terminals: effects on transmitter release.
    Miralles F; Marsal J; Peres J; Solsona C
    Brain Res; 1996 Apr; 714(1-2):192-200. PubMed ID: 8861625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial lipopolysaccharide depresses spontaneous, evoked, and ionophore-induced transmitter release at the neuromuscular junction.
    Person RJ
    J Neurosci Res; 1979; 4(2):105-14. PubMed ID: 229236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presynaptic inhibition of spontaneous acetylcholine release induced by adenosine at the mouse neuromuscular junction.
    De Lorenzo S; Veggetti M; Muchnik S; Losavio A
    Br J Pharmacol; 2004 May; 142(1):113-24. PubMed ID: 15066904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential modulation of evoked and spontaneous glycine release from rat spinal cord glycinergic terminals by the cyclic AMP/protein kinase A transduction cascade.
    Katsurabayashi S; Kubota H; Moorhouse AJ; Akaike N
    J Neurochem; 2004 Nov; 91(3):657-66. PubMed ID: 15485496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydropyridine-sensitive and -insensitive components of acetylcholine release from rat motor nerve terminals.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Nov; 251(2):672-8. PubMed ID: 2478694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urotensin II promotes vagal-mediated bradycardia by activating cardiac-projecting parasympathetic neurons of nucleus ambiguus.
    Brailoiu GC; Deliu E; Rabinowitz JE; Tilley DG; Koch WJ; Brailoiu E
    J Neurochem; 2014 May; 129(4):628-36. PubMed ID: 24521102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mg++ antagonism of a prejunctional opiate receptor mediated effect at the frog neuromuscular junction.
    Durham HD; Frank GB
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):72-82. PubMed ID: 6295295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human urotensin II modulates collagen synthesis and the expression of MMP-1 in human endothelial cells.
    Wang H; Mehta JL; Chen K; Zhang X; Li D
    J Cardiovasc Pharmacol; 2004 Nov; 44(5):577-81. PubMed ID: 15505495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcellular mechanism and site of action of ionic lanthanum at the motor nerve terminal.
    Provan SD; Miyamoto MD
    Neuroreport; 1992 Jan; 3(1):101-4. PubMed ID: 1319225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.